Cargando…
Update on cell therapy for stroke
Ischaemic stroke remains a leading cause of death and disability. Current stroke treatment options aim to minimise the damage from a pending stroke during the acute stroke period using intravenous thrombolytics and endovascular thrombectomy; however, there are no currently approved treatment options...
Autores principales: | Kenmuir, Cynthia L, Wechsler, Lawrence R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600013/ https://www.ncbi.nlm.nih.gov/pubmed/28959493 http://dx.doi.org/10.1136/svn-2017-000070 |
Ejemplares similares
-
Neurothrombectomy for Acute Ischemic Stroke Across Clinical Trial Design and Technique: A Single Center Pooled Analysis
por: Jovin, Tudor G., et al.
Publicado: (2020) -
The potential benefit of stem cell therapy after stroke: an update
por: Banerjee, Soma, et al.
Publicado: (2012) -
An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside
por: Dailey, Travis, et al.
Publicado: (2013) -
Updates on Prevention of Cardioembolic Strokes
por: Topcuoglu, Mehmet Akif, et al.
Publicado: (2018) -
Stroke Genetics: A Review and Update
por: Lindgren, Arne
Publicado: (2014)